Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Myelodysplastic Syndromes 62Hodgkin Disease 57Leukemia 56Leukemia, Lymphocytic, Chronic, B-Cell 55Multiple Myeloma 51Lymphoma, Non-Hodgkin 48Lymphoma 44Myeloproliferative Disorders 37Graft vs Host Disease 37Lymphoma, Follicular 36Congenital Abnormalities 36Lymphoma, Large B-Cell, Diffuse 35Leukemia, Myeloid, Accelerated Phase 35Lymphoma, Mantle-Cell 34Lymphoma, B-Cell, Marginal Zone 31Leukemia, Myeloid, Chronic-Phase 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Hematologic Neoplasms 29Burkitt Lymphoma 28Leukemia, Myelomonocytic, Chronic 27Blast Crisis 27Primary Myelofibrosis 26Neoplasms, Plasma Cell 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Waldenstrom Macroglobulinemia 17Lymphoma, T-Cell, Cutaneous 16Anemia, Refractory, with Excess of Blasts 16

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neoplasms × Tacrolimus × Clear all
NCT03680092 2025-10-02

Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

University of California, San Diego

Phase 2 Completed
43 enrolled 10 charts
Other hematologic neoplasm

Graft vs Host Disease, Neoplasms, Hematologic Neoplasms

NCT02566304 2025-04-24

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
35 enrolled 14 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00857389 2020-04-07

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

M.D. Anderson Cancer Center

Phase 2 Completed
60 enrolled 15 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡